Results 311 to 320 of about 1,294,431 (344)
Some of the next articles are maybe not open access.
Leukemia in an Infant Born of a Mother with Leukemia
New England Journal of Medicine, 1958THE literature contains many reports of patients with leukemia who have had pregnancies terminating successfully in the birth of normal infants.1 , 2 Thus far, no child born of a mother with leukemia has been observed to have the same disease.3 , 4 The present report concerns an infant in whom acute lymphocytic leukemia developed at nine months of age.
Henry G. Cramblett +2 more
openaire +3 more sources
2008
Benzene and Leukemia addresses leukemogenic effect of benzene, representing a complex model of chemical carcinogenesis in humans.
V. Bollati, A. Forni
openaire +1 more source
Benzene and Leukemia addresses leukemogenic effect of benzene, representing a complex model of chemical carcinogenesis in humans.
V. Bollati, A. Forni
openaire +1 more source
Leukemia cutis in acute lymphoblastic leukemia
Journal of the American Academy of Dermatology, 1994separating normal epidermis from a diffuse dermal infiltrate of lymphoid blast cells with round and regular nuclei, inconspicuous nucleoli, and scanty, moderately basophilic cytoplasm. Immunophenotype analysis revealed strong positivity for CD 10.The patient wastreated with methotrexate, teniposide, cytosine arabinoside, and local irradiation, and a ...
J.M. Forjaz de Lacerda +5 more
openaire +3 more sources
Pediatrics, 1986
To the Editor.— I enjoyed reading the paper by Aronis et al,1 and would like to bring to your attention that we have also recently observed leukemia in two patients with hemophilia A and B, 10 and 1½ years of age, respectively.2 Because commercial factor VIII and IX were not used and only blood, fresh frozen plasma, and plasma were given
openaire +3 more sources
To the Editor.— I enjoyed reading the paper by Aronis et al,1 and would like to bring to your attention that we have also recently observed leukemia in two patients with hemophilia A and B, 10 and 1½ years of age, respectively.2 Because commercial factor VIII and IX were not used and only blood, fresh frozen plasma, and plasma were given
openaire +3 more sources
Secondary leukemia or unfavorable leukemia?
Blood, 2003Secondary leukemia usually describes a myeloid leukemia that follows treatment with chemotherapy or radiation or an exposure to any leukemogen. Smith and colleagues (page [43][1]) describe a remarkable series, spanning 3 decades, of 306 consecutive patients with therapy-related myeloid leukemia ...
openaire +2 more sources
2012
A lifetime of sustained lymphohematopoiesis requires a stem cell compartment that produces maturing progeny with immaculate fidelity over almost a century. The stem cell gives rise to progenitor cells that are committed to either lymphoid or myeloid development.
openaire +1 more source
A lifetime of sustained lymphohematopoiesis requires a stem cell compartment that produces maturing progeny with immaculate fidelity over almost a century. The stem cell gives rise to progenitor cells that are committed to either lymphoid or myeloid development.
openaire +1 more source
Current Oncology Reports, 2001
Leukemia is susceptible to immune-mediated therapies such as allogeneic stem-cell transplantation, donor lymphocyte infusion, and interferon. The clinical effectiveness of these immune-based modalities has encouraged interest in vaccine therapies for leukemia.
Jeffrey J. Molldrem +1 more
openaire +3 more sources
Leukemia is susceptible to immune-mediated therapies such as allogeneic stem-cell transplantation, donor lymphocyte infusion, and interferon. The clinical effectiveness of these immune-based modalities has encouraged interest in vaccine therapies for leukemia.
Jeffrey J. Molldrem +1 more
openaire +3 more sources
2020
Leukemia is a malignant clonal disease that originates from hematopoietic stem cells. As in-depth research examines the molecular biology and immunology of the hematopoietic system, leukemia treatment has evolved from a single cytotoxic drug to treatments that inducing differentiation and apoptosis.
Wei-Li Zhao +4 more
openaire +2 more sources
Leukemia is a malignant clonal disease that originates from hematopoietic stem cells. As in-depth research examines the molecular biology and immunology of the hematopoietic system, leukemia treatment has evolved from a single cytotoxic drug to treatments that inducing differentiation and apoptosis.
Wei-Li Zhao +4 more
openaire +2 more sources
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2000
Heather Thompson Mackey, Paula Klemm
openaire +3 more sources
Heather Thompson Mackey, Paula Klemm
openaire +3 more sources
Myelodysplasia and the leukemias
Current Problems in Cancer, 1997The armistice after World War II marked the beginning of an era that was to last to the end of the present century. It was an era in which many changes in medicine and nursing combined to alter the entire philosophy of managing malignant disease. More specifically, the fluid-phase tumors, which comprise myelodysplasia and the leukemias, were singled ...
openaire +4 more sources